Clinical genetics continuously reveals surprising phenotypic diversity within rare monogenic disorders. Pathogenic variants in the T-complex protein 1 gene typically cause TCP1 neurodevelopmental disorder, an autosomal dominant condition characterized by developmental delay, intellectual impairment, epilepsy, and structural brain malformations. Historically, cortical dysgenesis in this syndrome predominantly manifested as polymicrogyria. However, recent clinical evidence demonstrates that the morphological spectrum is broader than clinicians previously realized. A newly documented pediatric presentation highlights how novel loss-of-function variants can produce profound developmental delay without epilepsy or classical cortical malformations. Consequently, pediatric neurologists and clinical geneticists must reassess their diagnostic assumptions when encountering atypical neuroimaging findings. Recognizing these non-canonical phenotypes allows healthcare teams to improve diagnostic yield, initiate targeted therapies earlier, and provide comprehensive family counseling.

Molecular Architecture of TCP1 Neurodevelopmental Disorder

The TCP1 gene encodes the TCP1α subunit, which forms a vital element of the chaperonin-containing TCP1 ring complex (TRiC). This massive molecular machine consists of two stacked rings containing eight distinct subunits. Crucially, the complex facilitates ATP-dependent protein folding for nearly ten percent of newly translated cytosolic proteins. Essential cytoskeletal proteins, specifically actin and tubulin, rely on TRiC chaperoning to achieve their functional conformations. When pathogenic variants disrupt TCP1, the assembly and enzymatic capability of the entire chaperonin ring suffer. Consequently, impaired cellular proteostasis disrupts critical neurodevelopmental processes, including neuronal migration and axonal transport. Most previously reported TCP1 variants involved missense alterations that compromised substrate binding or allosteric cooperativity. In contrast, the recently identified c.1392delT (p.A465Qfs*3) variant in exon 11 causes a frameshift mutation. This mutation truncates 16.5% of the carboxy-terminal protein sequence. Furthermore, bioinformatic predictive tools indicate that this premature truncation likely triggers nonsense-mediated mRNA decay, culminating in haploinsufficiency. Thus, distinct molecular mechanisms across different TCP1 variants may explain why phenotypic manifestations vary significantly among affected children.

Atypical Neuroimaging and Absence of Polymicrogyria

Classical descriptions of TRiC-related chaperonopathies frequently emphasize malformations of cortical development, particularly polymicrogyria. Because tubulin and actin dynamics govern radial migration and cortical layering, defective chaperonin activity typically impairs normal gyral formation. Therefore, clinicians traditionally anticipate cobblestone cortex or excessive microgyri on high-resolution magnetic resonance imaging. However, a four-year-old child harboring the c.1392delT frameshift variant exhibited a strikingly distinct neuroimaging phenotype. Notably, cerebral imaging revealed complete absence of the septum pellucidum accompanied by mild bilateral frontal sulcation asymmetry. Most importantly, the scan showed no evidence of polymicrogyria or lissencephaly. In addition, detailed imaging confirmed that both optic nerves and the pituitary gland maintained normal anatomical integrity. This finding effectively ruled out classical septo-optic dysplasia, which frequently features optic nerve hypoplasia and endocrinopathies. Nevertheless, medical experts cannot establish a definite causal relationship between TCP1 haploinsufficiency and absent septum pellucidum based on a single case report. Future cohort studies must determine whether midline forebrain dysgenesis represents a true extension of the TCP1 disease spectrum.

Clinical Presentation Beyond Classical Neurological Deficits

Patients presenting with TRiC complex disorders usually suffer from intractable early-onset epilepsy and pronounced spasticity. In sharp contrast, this pediatric patient remained completely seizure-free through four years of clinical follow-up. Her primary neurological manifestations included global developmental delay, severe expressive speech impairment, microcephaly, and axial hypotonia with core muscular weakness. Furthermore, detailed systemic evaluation uncovered significant extraneural features that expand the potential phenotypic purview of chaperonin dysfunction. The patient exhibited a congenital bicuspid aortic valve accompanied by mild aortic insufficiency. Additionally, she suffered from severe atopic disease, encompassing bronchial asthma, therapy-resistant eczema, and multiple food allergies. Currently, the pathogenic relationship between TCP1 disruption and these extraneural findings remains uncertain. Molecular chaperones like TRiC participate ubiquitously in embryogenesis and immune cell signaling. Therefore, defective folding of structural proteins in endothelial cells or immune receptors could theoretically predispose individuals to valvular defects or immunological hyper-reactivity. Clinicians should systematically document extraneural findings in newly diagnosed patients to clarify whether these phenotypes represent pleiotropic manifestations or incidental comorbidities.

Diagnostic Pathway and Genomic Interpretation in Pediatric Care

Navigating the diagnostic odyssey of complex neurodevelopmental delays requires modern genomic sequencing tools. When children present with unexplained developmental delay, microcephaly, and hypotonia, traditional chromosomal microarray analysis often returns non-diagnostic results. Consequently, whole exome sequencing and comprehensive multi-gene panels serve as pivotal frontline diagnostic modalities. Identifying novel heterozygous sequence changes in TCP1 requires meticulous adherence to American College of Medical Genetics and Genomics guidelines. For instance, the novel c.1392delT variant demonstrated complete absence from population databases like gnomAD, satisfying crucial rarity criteria. However, because biological parental genetic testing was unavailable, geneticists could not establish whether the variant arose de novo. De novo occurrence provides strong supporting evidence for pathogenicity in dominant disorders. Without parental confirmation, clinicians must rely on computational predictions, functional biochemical data, and loss-of-function constraint scores. Pediatric neurologists encountering novel candidate variants should submit these genomic findings to international registries like ClinVar. Collaborative data sharing enables international researchers to aggregate rare phenotypes, facilitating accurate variant classification and preventing diagnostic ambiguity for families.

Therapeutic Implications and Long-Term Multidisciplinary Care

Presently, no targeted disease-modifying therapies exist to restore TRiC chaperonin assembly or rescue deficient protein-folding capacity. Therefore, clinical management of affected children remains supportive, anticipatory, and fundamentally multidisciplinary. Because hypotonia and core weakness delay motor milestones, physical and occupational therapists should intervene promptly to promote functional independence. Simultaneously, early speech-language therapy and augmentative communication tools can alleviate severe expressive speech barriers, thereby diminishing behavioral frustration. Although this specific case lacked seizures, clinicians must maintain vigilance because classical TCP1-related disorders frequently induce pharmacoresistant epilepsy. Routine surveillance electroencephalograms and prompt evaluation of suspicious paroxysmal events remain vital throughout childhood. In addition, the presence of bicuspid aortic valve warrants routine pediatric cardiology surveillance, including serial echocardiography to monitor aortic root dimensions. Similarly, pediatric allergy and immunology specialists must supervise severe atopic dermatitis and food allergies through rigorous avoidance protocols. Ultimately, an integrated care model combining neurology, cardiology, clinical genetics, and therapy teams guarantees the best possible quality of life for these complex pediatric patients.

Frequently Asked Questions

What defines TCP1 neurodevelopmental disorder in pediatric neurology?

TCP1 neurodevelopmental disorder represents an autosomal dominant genetic syndrome caused by heterozygous variants in the TCP1 gene. This gene encodes a critical subunit of the TRiC chaperonin complex responsible for folding cytoskeletal and cytosolic proteins. Clinically, classical presentations feature global developmental delay, intellectual disability, early-onset seizures, microcephaly, and structural cortical malformations such as polymicrogyria. However, emerging clinical reports illustrate that affected patients can sometimes present without epilepsy or typical cortical dysgenesis.

How does an absent septum pellucidum affect clinical diagnosis?

An absent septum pellucidum represents a midline brain malformation that commonly prompts investigation for septo-optic dysplasia or holoprosencephaly. When identified on pediatric neuroimaging, clinicians must evaluate optic nerve morphology, visual evoked potentials, and hypothalamic-pituitary endocrine axes. However, isolated absent septum pellucidum can occur without hormonal deficiencies or ocular involvement. In the context of rare genetic mutations like TCP1 variants, identifying this midline anomaly suggests an expanding neuroimaging spectrum that warrants comprehensive multidisciplinary follow-up.

What monitoring is recommended for children diagnosed with TCP1 variants?

Children diagnosed with pathogenic TCP1 variants require comprehensive, ongoing multidisciplinary monitoring across multiple organ systems. Neurologists should conduct periodic clinical examinations and electroencephalography to detect late-onset epilepsy. Simultaneously, physical, occupational, and speech therapists should support motor development and functional communication. Furthermore, because novel presentations highlight potential extraneural manifestations, baseline pediatric cardiology evaluation with echocardiography and proactive management of severe allergic disease or asthma are recommended to address possible non-neurological comorbidities effectively.

Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.

References

1. Biton D et al. Absent Septum Pellucidum Without Polymicrogyria or Seizures in TCP1-Related Neurodevelopmental Disorder. Am J Med Genet A. 2026 Oct 19. doi: 10.1002/ajmg.a.70335. PMID: 42897101.
2. Posocco P, et al. Brain malformations and seizures by impaired chaperonin function of TRiC. Science. 2021;374(6571):eabk0263.
3. Severino M, et al. Definitions and classification of malformations of cortical development: practical guidance. Brain. 2020;143(10):2874-2894.